Jefferies Financial Group Has Lowered Expectations for Croda International (LON:CRDA) Stock Price

Key Points

• Jefferies Financial Group has reduced the price target for Croda International from GBX 3,200 to GBX 3,100, while maintaining a "buy" rating on the stock.
• Other analysts, including Citigroup and Deutsche Bank, have also lowered their price targets for Croda International, with the current average price target at GBX 3,062.50.
• Despite recent stock price declines, insiders have shown confidence by purchasing shares, acquiring a total of 11,333 shares worth approximately $29.8 million in the last three months.

Croda International (LON:CRDA - Get Free Report) had its price objective dropped by equities researchers at Jefferies Financial Group from GBX 3,200 to GBX 3,100 in a research note issued on Friday,Digital Look reports. The firm presently has a "buy" rating on the stock. Jefferies Financial Group's target price suggests a potential upside of 9.71% from the stock's previous close.

Other research analysts have also recently issued reports about the company. Citigroup lowered their price objective on Croda International from GBX 3,300 to GBX 3,050 and set a "neutral" rating for the company in a research report on Friday, October 3rd. Deutsche Bank Aktiengesellschaft lowered their price objective on Croda International from GBX 3,400 to GBX 3,000 and set a "hold" rating for the company in a research report on Tuesday, July 29th. JPMorgan Chase & Co. raised Croda International to an "overweight" rating in a research report on Wednesday, July 30th. Finally, Berenberg Bank lowered their price objective on Croda International from GBX 3,800 to GBX 3,100 and set a "buy" rating for the company in a research report on Tuesday, July 29th. Three research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of GBX 3,062.50.

Croda International Trading Down 2.5%

CRDA opened at GBX 2,825.64 on Friday. Croda International has a 12 month low of GBX 2,426.77 and a 12 month high of GBX 3,821. The stock has a market capitalization of £3.94 billion, a price-to-earnings ratio of 1,834.83, a PEG ratio of 1.40 and a beta of 0.74. The company has a debt-to-equity ratio of 30.90, a current ratio of 2.72 and a quick ratio of 2.25. The business has a fifty day moving average price of GBX 2,611.45 and a 200 day moving average price of GBX 2,817.31.

Croda International (LON:CRDA - Get Free Report) last released its earnings results on Tuesday, July 29th. The company reported GBX 72.20 EPS for the quarter. Croda International had a return on equity of 6.96% and a net margin of 9.98%. Sell-side analysts expect that Croda International will post 181.8307268 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, insider Jacqui Ferguson bought 393 shares of Croda International stock in a transaction dated Friday, August 22nd. The stock was acquired at an average cost of GBX 2,524 per share, with a total value of £9,919.32. Also, insider Danuta Gray bought 545 shares of Croda International stock in a transaction dated Friday, August 22nd. The stock was purchased at an average cost of GBX 2,550 per share, with a total value of £13,897.50. In the last three months, insiders bought 11,333 shares of company stock worth $29,793,789. Corporate insiders own 0.83% of the company's stock.

About Croda International

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.